Kittikraisak Wanitchaya, Suntarattiwong Piyarat, Ditsungnoen Darunee, Klungthong Chonticha, Fernandez Stefan, Yoon In-Kyu, Lindblade Kim, Dawood Fatimah S, Olsen Sonja J, Chotpitayasunondh Tawee
From the *Influenza Program, Thailand Ministry of Public Health - US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand; †Queen Sirikit National Institute of Child Health, Ministry of Public Health, Bangkok, Thailand; ‡Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; §International Vaccine Institute, Seoul, Korea; and ¶Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia.
Pediatr Infect Dis J. 2016 Oct;35(10):e318-25. doi: 10.1097/INF.0000000000001280.
The Thai Advisory Committee on Immunization Practices recommends annual influenza vaccination for children 6 months through 2 years of age, although older children may be vaccinated on request. We evaluated the effectiveness of the 2013 and 2014 inactivated influenza vaccines to reduce medically attended, laboratory-confirmed influenza illness among Thai children aged 7-60 months.
From September 2013-May 2015, children with influenza-like illness were screened with a rapid influenza diagnostic test. Enrolled children had nasal and throat swabs tested for influenza viruses using polymerase chain reaction. Cases and controls were subjects testing positive and negative, respectively, for influenza viruses by polymerase chain reaction. Vaccination status was ascertained from vaccination cards. Vaccine effectiveness (VE) was calculated as 100% × (1 - odds ratio of vaccination among cases vs. controls).
Of the 1377 children enrolled, cases (n = 490) and controls (n = 887) were similar in demographic characteristics. Cases were less likely to receive influenza vaccine than controls in 2013 (6% vs. 14%; P = 0.02), but not in 2014 (6% vs. 7%; P = 0.57). Among cases, 126 (26%) were positive for influenza A(H1N1)pdm09 virus, 239 (49%) for influenza A(H3N2) and 124 (25%) for influenza B. One specimen was positive for both influenza A(H3N2) and B viruses. VE for full vaccination against all viruses was 64% (95% confidence interval: 21% to 84%) in 2013 and 26% (95% confidence interval: -47% to 63%) in 2014.
Influenza vaccination was low among Thai children in this study, and VE varied by year, highlighting the need for annual monitoring of VE to better understand vaccine program effectiveness.
泰国免疫实践咨询委员会建议,对6个月至2岁的儿童每年进行流感疫苗接种,年龄较大的儿童如有需要也可接种。我们评估了2013年和2014年的灭活流感疫苗在减少7至60个月大的泰国儿童中因医学就诊、实验室确诊的流感疾病方面的有效性。
2013年9月至2015年5月,对患有流感样疾病的儿童进行快速流感诊断检测筛查。对入组儿童的鼻拭子和咽拭子使用聚合酶链反应检测流感病毒。病例组和对照组分别是通过聚合酶链反应检测流感病毒呈阳性和阴性的受试者。从疫苗接种卡确定疫苗接种状况。疫苗有效性(VE)计算为100%×(1 - 病例组与对照组接种疫苗的比值比)。
在1377名入组儿童中,病例组(n = 490)和对照组(n = 887)在人口统计学特征方面相似。2013年病例组接种流感疫苗的可能性低于对照组(6%对14%;P = 0.02),但2014年并非如此(6%对7%;P = 0.57)。在病例组中,126例(26%)甲型(H1N1)pdm09流感病毒呈阳性,239例(49%)甲型(H3N2)流感病毒呈阳性,124例(25%)乙型流感病毒呈阳性。一份标本同时对甲型(H3N2)和乙型流感病毒呈阳性。2013年针对所有病毒的全程接种疫苗有效性为64%(95%置信区间:21%至84%),2014年为26%(95%置信区间:−47%至63%)。
本研究中泰国儿童的流感疫苗接种率较低,且疫苗有效性因年份而异,这突出表明需要每年监测疫苗有效性,以更好地了解疫苗计划的效果。